High IFIT1 expression predicts improved clinical outcome, and IFIT1 along with MGMT more accurately predicts prognosis in newly diagnosed glioblastoma

Human Pathology

Volumn 52, Issue , 2016, Pages 136-144

  Zhang, Jin Feng ^a   Chen, Yao ^a   Lin, Guo Shi ^a   Zhang, Jian Dong ^a   Tang, Wen Long ^a   Huang, Jian Huang ^b   Chen, Jin Shou ^c   Wang, Xing Fu ^a   Lin, Zhi Xiong ^a,d  

^a FUJIAN MEDICAL UNIVERSITY   (China)

^b PUTIAN UNIVERSITY   (China)

^c Hospital of Xianyou county   (China)

^d CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

Glioblastoma; IFIT1; IFN; MGMT; Prognosis

Indexed keywords

INTERFERON INDUCED PROTEIN WITH TETRATRICOPEPTIDE REPEAT 1; KI 67 ANTIGEN; METHYLATED DNA PROTEIN CYSTEINE METHYLTRANSFERASE; TEMOZOLOMIDE; TETRATRICOPEPTIDE REPEAT PROTEIN; UNCLASSIFIED DRUG; CARRIER PROTEIN; DNA LIGASE; DNA METHYLTRANSFERASE; IFIT1 PROTEIN, HUMAN; MGMT PROTEIN, HUMAN; TUMOR MARKER; TUMOR SUPPRESSOR PROTEIN;

ADJUVANT CHEMORADIOTHERAPY; ADULT; ARTICLE; BRAIN TISSUE; CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER GROWTH; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; CLINICAL FEATURE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; FEMALE; FOLLOW UP; GLIOBLASTOMA; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; MULTIPLE CYCLE TREATMENT; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PROGRESSION FREE SURVIVAL; PROTEIN EXPRESSION; RETROSPECTIVE STUDY; BRAIN NEOPLASMS; CHI SQUARE DISTRIBUTION; DISEASE FREE SURVIVAL; ENZYMOLOGY; KAPLAN MEIER METHOD; MORTALITY; MULTIVARIATE ANALYSIS; PATHOLOGY; PREDICTIVE VALUE; RISK FACTOR; TIME FACTOR; TREATMENT OUTCOME; UPREGULATION;

BIOMARKERS, TUMOR; BRAIN NEOPLASMS; CARRIER PROTEINS; CHI-SQUARE DISTRIBUTION; DISEASE-FREE SURVIVAL; DNA MODIFICATION METHYLASES; DNA REPAIR ENZYMES; FEMALE; GLIOBLASTOMA; HUMANS; IMMUNOHISTOCHEMISTRY; KAPLAN-MEIER ESTIMATE; KI-67 ANTIGEN; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PREDICTIVE VALUE OF TESTS; RETROSPECTIVE STUDIES; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME; TUMOR SUPPRESSOR PROTEINS; UP-REGULATION;

EID: 84962719293     PISSN: 00468177     EISSN: 15328392     Source Type: Journal    
DOI: 10.1016/j.humpath.2016.01.013     Document Type: Article

References (32)

1. B.H. Rath, J.M. Fair, M. Jamal, K. Camphausen, and P.J. Tofilon Astrocytes enhance the invasion potential of glioblastoma stem-like cells PLoS One 8 2013 e54752 10.1371/journal.pone.0054752
2. D. Stieber, A. Golebiewska, L. Evers, and et al. Glioblastomas are composed of genetically divergent clones with distinct tumourigenic potential and variable stem cell-associated phenotypes Acta Neuropathol 127 2014 203 219
3. H. Kawaji, T. Tokuyama, T. Yamasaki, S. Amano, N. Sakai, and H. Namba Interferon-beta and temozolomide combination therapy for temozolomide monotherapy-refractory malignant gliomas Mol Clin Oncol 3 2015 909 913
4. T. Wakabayashi, T. Kayama, R. Nishikawa, and et al. A multicenter phase I trial of combination therapy with interferon-beta and temozolomide for high-grade gliomas (INTEGRA study): the final report J Neuro-Oncol 104 2011 573 577
5. N. Bektas, E. Noetzel, J. Veeck, and et al. The ubiquitin-like molecule interferon-stimulated gene 15 (ISG15) is a potential prognostic marker in human breast cancer Breast Cancer Res 10 2008 R58 10.1186/bcr2117
6. H. Zali, and Tavirani M. Rezaei Meningioma protein-protein interaction network Arch Iran Med 17 2014 262 272
7. H.H. Danish, S. Goyal, N.K. Taunk, H. Wu, M.S. Moran, and B.G. Haffty Interferon-induced protein with tetratricopeptide repeats 1 (IFIT1) as a prognostic marker for local control in T1-2 N0 breast cancer treated with breast-conserving surgery and radiation therapy (BCS + RT) Breast J 19 2013 231 239
8. M. Wathelet, S. Moutschen, P. Defilippi, and et al. Molecular cloning, full-length sequence and preliminary characterization of a 56-kDa protein induced by human interferons Eur J Biochem 155 1986 11 17
9. S.D. Der, A. Zhou, B.R. Williams, and R.H. Silverman Identification of genes differentially regulated by interferon alpha, beta, or gamma using oligonucleotide arrays Proc Natl Acad Sci U S A 95 1998 15623 15628
10. K. Motomura, A. Natsume, Y. Kishida, and et al. Benefits of interferon-beta and temozolomide combination therapy for newly diagnosed primary glioblastoma with the unmethylated MGMT promoter: a multicenter study Cancer 117 2011 1721 1730
11. S.F. Rosati, R.F. Williams, L.C. Nunnally, and et al. IFN-beta sensitizes neuroblastoma to the antitumor activity of temozolomide by modulating O-6-methylguanine DNA methyltransferase expression Mol Cancer Ther 7 2008 3852 3858
12. T. Imaizumi, K. Murakami, K. Ohta, and et al. MDA5 and ISG56 mediate CXCL10 expression induced by toll-like receptor 4 activation in U373MG human astrocytoma cells Neurosci Res 76 2013 195 206
13. I. Larsson, L.E. Landstrom, E. Larner, E. Lundgren, H. Miorner, and L. Strannegard Interferon production in glia and glioma cell lines Infect Immun 22 1978 786 789
14. D.J. Brat, B.W. Scheithauer, G.N. Fuller, and T. Tihan Newly codified glial neoplasms of the 2007 WHO classification of tumours of the central nervous system: angiocentric glioma, pilomyxoid astrocytoma and pituicytoma Brain Pathol 17 2007 319 324
15. P.Y. Wen, D.R. Macdonald, D.A. Reardon, and et al. Updated response assessment criteria for high-grade gliomas: response assessment in neuro-oncology working group J Clin Oncol 28 2010 1963 1972
16. L.B. Chambless, H.M. Kistka, S.L. Parker, L. Hassam-Malani, M.J. McGirt, and R.C. Thompson The relative value of postoperative versus preoperative Karnofsky Performance Scale scores as a predictor of survival after surgical resection of glioblastoma multiforme J Neuro-Oncol 121 2015 359 364
17. C.X. Wu, G.S. Lin, Z.X. Lin, J.D. Zhang, S.Y. Liu, and C.F. Zhou Peritumoral edema shown by MRI predicts poor clinical outcome in glioblastoma World J Surg Oncol 13 2015 97 10.1186/s12957-015-0496-7
18. J.P. Almeida, K.L. Chaichana, J. Rincon-Torroella, and A. Quinones-Hinojosa The value of extent of resection of glioblastomas: clinical evidence and current approach Curr Neurol Neurosci Rep 15 2015 517 10.1007/s11910-014-0517-x
19. K.L. Chaichana, E.E. Cabrera-Aldana, I. Jusue-Torres, and et al. When gross total resection of a glioblastoma is possible, how much resection should be achieved? World Neurosurg 82 2014 e257 e265
20. L.J. Yang, C.F. Zhou, and Z.X. Lin Temozolomide and radiotherapy for newly diagnosed glioblastoma multiforme: a systematic review Cancer Investig 32 2014 31 36
21. M.Z. Sun, T. Oh, M.E. Ivan, and et al. Survival impact of time to initiation of chemoradiotherapy after resection of newly diagnosed glioblastoma J Neurosurg 122 2015 1144 1150
22. M.N. Thuy, J.K. Kam, G.C. Lee, and et al. A novel literature-based approach to identify genetic and molecular predictors of survival in glioblastoma multiforme: analysis of 14,678 patients using systematic review and meta-analytical tools J Clin Neurosci 22 2015 785 799
23. C.A. Clara, S.K. Marie, J.R. de Almeida, and et al. Angiogenesis and expression of PDGF-C, VEGF, CD105 and HIF-1alpha in human glioblastoma Neuropathology 34 2014 343 352
24. Q.G. D'Alessandris, M. Martini, T. Cenci, and et al. VEGF isoforms as outcome biomarker for anti-angiogenic therapy in recurrent glioblastoma Neurology 84 2015 1906 1908
25. Y. Ruano, T. Ribalta, A.R. de Lope, and et al. Worse outcome in primary glioblastoma multiforme with concurrent epidermal growth factor receptor and p53 alteration Am J Clin Pathol 131 2009 257 263
26. X.X. Qiu, L. Chen, C.H. Wang, and et al. High delta-like ligand 4 (DLL4) is correlated with peritumoral brain edema and predicts poor prognosis in primary glioblastoma Medicine 93 2014 e57
27. G.S. Lin, L.J. Yang, X.F. Wang, and et al. STAT3 Tyr705 phosphorylation affects clinical outcome in patients with newly diagnosed supratentorial glioblastoma Med Oncol 31 2014 924 10.1007/s12032-014-0924-5
28. L.D. D'Andrea, and L. Regan TPR proteins: the versatile helix Trends Biochem Sci 28 2003 655 662
29. J. Guo, D.J. Hui, W.C. Merrick, and G.C. Sen A new pathway of translational regulation mediated by eukaryotic initiation factor 3 EMBO J 19 2000 6891 6899
30. Y.A. Hsu, H.J. Lin, J.J. Sheu, and et al. A novel interaction between interferon-inducible protein p56 and ribosomal protein L15 in gastric cancer cells DNA Cell Biol 30 2011 671 679
31. N.C. Reich A death-promoting role for ISG54/IFIT2 J Interferon Cytokine Res 33 2013 199 205
32. M. Stawowczyk, S. Van Scoy, K.P. Kumar, and N.C. Reich The interferon stimulated gene 54 promotes apoptosis J Biol Chem 286 2011 7257 7266